(Q30451209)

21 June 2017

1 reference

title

History of outcome measures for myasthenia gravis (English)

1 reference

21 June 2017

0 references

1

Ted M Burns

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

21 June 2017

1 reference

21 June 2017

volume

42

1 reference

21 June 2017

issue

1

1 reference

21 June 2017

page(s)

5-13

1 reference

Clinical-evaluation of ACTH and cortisone in myasthenia gravis.

21 June 2017

cites work

1 reference

Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment.

21 January 2018

1 reference

Studies in myasthenia gravis; review of two hundred eighty-two cases at the Mount Sinai Hospital, New York City

21 January 2018

1 reference

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America

21 January 2018

1 reference

Mycophenolate mofetil for myasthenia gravis: an open-label pilot study

21 January 2018

1 reference

Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases

21 January 2018

1 reference

A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group

21 January 2018

1 reference

Errors of measurement affecting the reliability and validity of data acquired from self-assessed quality of life

21 January 2018

1 reference

Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MUS.21713

1 reference

21 June 2017

1 reference